A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
Public ClinicalTrials.gov record NCT01220115. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.
Study identification
- NCT ID
- NCT01220115
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 498 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2010 (Type not available)
- Primary completion
- Sep 2014 (Actual)
- Completion
- Sep 2014 (Actual)
- Last update posted
- Dec 9, 2019
2010 – 2014
United States locations
- U.S. sites
- 42
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Services of Arkansas | Little Rock | Arkansas | 72205 | — |
| Children's Hospital Oakland (CHO) | Oakland | California | 94609 | — |
| Children's Hospital of Orange County Sickle Cell Disease Center | Orange | California | 92668 | — |
| Rady Children's Hopsital / UC San Diego University Hospital Sickle Cell Disease Center | San Diego | California | 92123 | — |
| Hematology Oncology, P.C. | Stamford | Connecticut | 06902 | — |
| Howard University | Washington D.C. | District of Columbia | 20060 | — |
| Broward Oncology Associates, P.A. | Fort Lauderdale | Florida | 33308 | — |
| Miami Children's Hospital | Miami | Florida | 33155 | — |
| Innovative Medical Research | Miami | Florida | 33179 | — |
| M.D. Anderson Cancer Center Orlando | Orlando | Florida | 32806 | — |
| All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| Central Tampa Hematology and Oncology Associates | Tampa | Florida | 33607 | — |
| St. Joseph Children's Hospital | Tampa | Florida | 33607 | — |
| University of Illinois at Chicago, Dept of Pediatrics | Chicago | Illinois | 60612 | — |
| Abington Hematology Oncology Associates, Inc | Oak Lawn | Illinois | 60453 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112 | — |
| LSU Department of Pediatrics Children's Hospital | New Orleans | Louisiana | 70118 | — |
| Johns Hopkins University Division of Hematology | Baltimore | Maryland | 21205 | — |
| Oncology-Hematology Associates, P.A. | Clinton | Maryland | 20735 | — |
| Children's Hospital Boston - Harvard | Boston | Massachusetts | 02115 | — |
| Boston Comprehensive Sickle Cell Center | Boston | Massachusetts | 02118 | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007-3731 | — |
| University of Missouri Child Health, Division of Pediatric Hematology/Oncology | Columbia | Missouri | 65212 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Research Medical Center | Kansas City | Missouri | 64132 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| Maimonides Medical Center | Brooklyn | New York | 11209 | — |
| New York Methodist Hospital Dept of Med/Sickle Cell Program | Brooklyn | New York | 11215 | — |
| Interfaith Medical Center-Comprehensive Sickle Cell Program | Brooklyn | New York | 11238 | — |
| Cohen Children's Medical Center of NY (CCMC) | New Hyde Park | New York | 11040 | — |
| Center for Children's Cancer & Blood Disorders | Syracuse | New York | 13210 | — |
| Presbyterian Hospital Pediatric Sickle Cell Program | Charlotte | North Carolina | 28204 | — |
| Ohio Region VI Sickle Cell Program | Akron | Ohio | 44308 | — |
| Cincinnati Children's Medical Center | Cincinnati | Ohio | 45229-3039 | — |
| The Children's Medical Center of Dayton | Dayton | Ohio | 45404 | — |
| Medical University of SC-Pediatric Sickle Cell Center | Charleston | South Carolina | 29425 | — |
| M. Francisco Gonzalez, M.D., P.A. | Columbia | South Carolina | 29203 | — |
| Diggs-Kraus Sickle Cell Center | Memphis | Tennessee | 38103 | — |
| Meharry Comprehensive Sickle Cell Center | Nashville | Tennessee | 37208 | — |
| Sickle Cell Disease and Hemoglobinopathy Clinic Children's Hospital at Vanderbilt | Nashville | Tennessee | 37232-6310 | — |
| Baylor College of Medicine-Texas Children's Hospital | Houston | Texas | 77030-2399 | — |
| Peninsula Cancer Institute | Newport News | Virginia | 23601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01220115, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2019 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01220115 live on ClinicalTrials.gov.